QGEN - Qiagen NV - Stock Price & Dividends
Exchange: USA Stocks • Country: Netherlands • Currency: USD • Type: Common Stock • ISIN: NL0015001WM6
Nucleic Acid, Purification, Instruments, Assays, PCR, Consumables
QIAGEN N.V. offers sample to insight solutions that transform biological materials into molecular insights worldwide. The company provides primary sample technology consumables, such as nucleic stabilization and purification kits for primary sample materials, manual and automated processing for genotyping, gene expression, and viral and bacterial analysis, as well as silica membranes and magnetic bead technologies; secondary sample technology consumables, including kits and components for purification of nucleic acids from secondary sample materials; and instruments for nucleic acid purification and accessories. It also provides interferon-gamma release assay for TB testing, and assays for post-transplant testing and viral load monitoring; assays for prenatal testing and detection of sexually transmitted diseases and HPV, as well as assays for analysis of genomic variants, such as mutations, insertions, deletions, and fusions; and sample to insight instruments, including one-step molecular analysis of hard-to-diagnose syndromes, and integrated PCR testing. In addition, it offers PCR consumables, such as quantitative PCR, reverse transcription, and combinations kits for analysis of gene expression, genotyping and gene regulation, and running on QIAGEN instruments and technologies; human ID and forensics assay consumables, including STR assays for human ID, and assays for food contamination; PCR instruments consist of digital PCR and qPCR solutions; and developed and configured enzymes and PCR solutions. Further, the company provides predefined and custom NGS gene panels, library prep kits and components, and whole genome amplification; QIAGEN consumables and instruments, as well as bioinformatics solutions; and custom laboratory and genomic services. It serves molecular diagnostics, academia, pharmaceutical, and applied testing customers. It has a collaboration with the U.S. FBI. The company was founded in 1984 and is headquartered in Venlo, the Netherlands. Web URL: https://www.qiagen.com
Drawdown (Underwater) Chart
Overall Trend and Yearly Seasonality
QGEN Stock Overview
Market Cap in USD | 10,201m |
Sector | Healthcare |
Industry | Diagnostics & Research |
GiC SubIndustry | Life Sciences Tools & Services |
TER | 0.00% |
IPO / Inception | 1996-06-28 |
QGEN Stock Ratings
Growth 5y | 19.1 |
Fundamental | 55.2 |
Dividend | 37.8 |
Rel. Performance vs Sector | -0.36 |
Analysts | 4.00/5 |
Fair Price Momentum | 44.24 USD |
Fair Price DCF | 45.49 USD |
QGEN Dividends
Dividend Yield 12m | 2.85% |
Yield on Cost 5y | 3.88% |
Dividends CAGR 5y | 0.00% |
Payout Consistency | 100.0% |
QGEN Growth Ratios
Growth 12m | 12.76% |
Growth Correlation 12m | 59% |
Growth Correlation 3m | 78% |
CAGR 5y | 6.36% |
CAGR/Mean DD 5y | 0.44 |
Sharpe Ratio 12m | 0.35 |
Alpha vs SP500 12m | -2.06 |
Beta vs SP500 5y weekly | 0.43 |
ValueRay RSI | 72.23 |
Volatility GJR Garch 1y | 21.64% |
Price / SMA 50 | 4.51% |
Price / SMA 200 | 6.84% |
Current Volume | 947k |
Average Volume 20d | 1445.9k |
External Links for QGEN Stock
News
Wall Street Journal • Benzinga • Yahoo Finance
Tweets
X • Stocktwits
Fund Manager Positions
Dataroma • Stockcircle
Wall Street Journal • Benzinga • Yahoo Finance
Tweets
X • Stocktwits
Fund Manager Positions
Dataroma • Stockcircle
What is the price of QGEN stocks?
As of September 14, 2024, the stock is trading at USD 46.36 with a total of 946,981 shares traded.
Over the past week, the price has changed by +2.45%, over one month by +0.71%, over three months by +3.03% and over the past year by +10.84%.
As of September 14, 2024, the stock is trading at USD 46.36 with a total of 946,981 shares traded.
Over the past week, the price has changed by +2.45%, over one month by +0.71%, over three months by +3.03% and over the past year by +10.84%.
What are the forecast for QGEN stock price target?
According to ValueRays Forecast Model, QGEN Qiagen NV will be worth about 48 in September 2025. The stock is currently trading at 46.36. This means that the stock has a potential upside of +3.62%.
According to ValueRays Forecast Model, QGEN Qiagen NV will be worth about 48 in September 2025. The stock is currently trading at 46.36. This means that the stock has a potential upside of +3.62%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 50.6 | 9.17 |
Analysts Target Price | 50.2 | 8.28 |
ValueRay Target Price | 48 | 3.62 |